Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio


MEMORIAL DAY FLASH SALE: 50% OFF BENZINGA PRO

As we honor our freedom, take a stand today. Secure the financial freedom that both you and your family deserve. Get exclusive market moving news for just 50% off.  Claim your 50% discount here.


Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

MEMORIAL DAY FLASH SALE: 50% OFF BENZINGA PRO

As we honor our freedom, take a stand today. Secure the financial freedom that both you and your family deserve. Get exclusive market moving news for just 50% off.  Claim your 50% discount here.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Trading IdeasBiotechnology IndustryLarge-CapPEG ratio